Liposome drug products
Executive Summary
FDA's Pharmaceutical Science Advisory Committee will discuss pharmaceutical equivalence, bioavailability and bioequivalence of liposome drug products on July 20. The committee will also receive updates on FDA research in dermatopharmacokinetics, and comment on methods to determine drug transfer into breastmilk